| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Tuesday, February 06, 2024 3:33:55 PM
Saying "IF" indicates that the company is working on projects like every other Biotech does.
The buccy defense testing and the micro needle patch collaboration are just two examples of said possibilities....not once have I ever indicated that anything was guaranteed hence my continuous usage of "IF".
If Revive had nothing as you claim then there would be no purpose for the testing on the behalf of these external entities eejit.
That said please do regale us some more with this fine display of grammatical idiocy!!!
The buccy defense testing and the micro needle patch collaboration are just two examples of said possibilities....not once have I ever indicated that anything was guaranteed hence my continuous usage of "IF".
If Revive had nothing as you claim then there would be no purpose for the testing on the behalf of these external entities eejit.
That said please do regale us some more with this fine display of grammatical idiocy!!!
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
